The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities and they are not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
Filed Pursuant to Rule 424(b)(2)
Registration No. 333-255829
SUBJECT TO COMPLETION, DATED FEBRUARY 5, 2024
Prospectus Supplement to Prospectus dated May 6, 2021
$
Becton, Dickinson and Company
$ % Notes due 20
$ % Notes due 20
We are offering $ aggregate principal amount of % Notes due 20 (the “20 notes”) and $ aggregate principal amount of % Notes due 20 (the “20 notes” and, together with the 20 notes, the “notes”). Interest on the notes will be payable in cash semi-annually in arrears on and of each year, beginning on , 2024. The 20 notes will mature on , 20 and the 20 notes will mature on , 20 .
We may, at our option, redeem the notes of each series, in whole or in part, at any time and from time to time, at the applicable redemption prices described in this prospectus supplement. See “Description of Notes—Optional Redemption.” In addition, if a change of control triggering event occurs in respect of a series of notes as described in this prospectus supplement under the heading “Description of Notes—Offer to Repurchase Upon Change of Control Triggering Event,” unless we have exercised our right to redeem such notes as described under “Description of Notes—Optional Redemption” we will be required to offer to purchase such notes from the holders.
Concurrently with this offering, we are also offering € aggregate principal amount of % Notes due 20 (the “concurrent offering”). The closings of this offering and the concurrent offering are not conditioned on each other. The concurrent offering is being made by means of a separate prospectus supplement and not by means of this prospectus supplement. This prospectus supplement is not an offer to sell or a solicitation of an offer to buy any securities being offered in the concurrent offering.
We expect to use the net proceeds from the concurrent offering to repay the $144 million aggregate principal amount outstanding of our 3.875% Notes due 2024, and the $998 million aggregate principal amount outstanding of our 3.363% Notes due 2024, and to use cash on hand to pay accrued interest, related premiums, fees and expenses in connection therewith. We expect to use the net proceeds from this offering to repay the $998 million aggregate principal amount outstanding of our 3.363% Notes due 2024, and the $875 million aggregate principal amount outstanding of our 3.734% Notes due 2024, and to use cash on hand to pay accrued interest, related premiums, fees and expenses in connection therewith. See “Use of Proceeds.”
Pending the final application of the net proceeds of this offering and the concurrent offering, we may use such proceeds temporarily for general corporate purposes. See “Use of Proceeds.”
The notes will be our senior unsecured obligations and will rank equally in right of payment with all of our other senior unsecured indebtedness, including our other outstanding senior notes. The notes will be issued in minimum denominations of $1,000 and in integral multiples of $1,000 in excess thereof.
The notes will not be listed on any securities exchange.
Investing in the notes involves risks that are described in the “Risk Factors” section of this prospectus supplement beginning on page S-
6 and in our latest Annual Report on Form 10-K, which is incorporated by reference into this prospectus supplement (as such risk factors may be updated from time to time in our public filings).
Neither the Securities and Exchange Commission (the “SEC”) nor any other regulatory body has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus supplement or the related prospectus. Any representation to the contrary is a criminal offense.
20 Notes
|
|
|
% |
|
|
$ |
|
|
% |
|
|
$ |
|
|
% |
|
|
$ |
20 Notes
|
|
|
% |
|
|
$ |
|
|
% |
|
|
$ |
|
|
% |
|
|
$ |
Total
|
|
|
|
|
|
$ |
|
|
|
|
|
$ |
|
|
|
|
|
$ |
(1)
|
Plus accrued interest from , 2024, if settlement occurs after that date. |
The underwriters expect to deliver the notes to purchasers in book-entry form only through the facilities of The Depository Trust Company (“DTC”), including its participants Clearstream Banking S.A. (“Clearstream”) and Euroclear Bank SA/NV (“Euroclear”), against payment in New York, New York on or about , 2024.
Joint Book-Running Managers
Barclays |
|
|
BNP PARIBAS |
|
|
Citigroup |
|
|
J.P. Morgan |
|
|
Morgan Stanley |
The date of this prospectus supplement is , 2024.